Addressing a press conference here to announce the launch of 'Zap n Clear', Mr Sehgal said the company was targeting a turnover of Rs 40 crore through the sale of 'Zap n Clear' itself. Claiming that his company was responsible for creating the anti-marks category in India with its product 'NoMarks', Mr Sehgal said the Ozone Group, which was started with an investment of Rs three crore in 1992, had achieved a turnover of Rs 112 crore during 2006-07.
He said 'Zap n Clear', an ayurvedic formulation, consists of a twin tube pack which treats and cures pimples and works on the marks as well. An anti-acne face wash was also being launched along with 'Zap n Clear' while anti-acne cream, face pack and scrub were in the pipeline.
Mr Sehgal said the anti-acne products market in India had a relatively modest turnover of Rs 65 crore and the sector was waiting for a breakthrough product to boost sales. The entire skincare market in the country was worth Rs 12,000 crore and was growing at 20 per cent per annum.
Describing the Ozone Group as a 'speciality neutral' company, he said it was manufacturing both allopathic and ayurvedic products.
Among its prescription allopathic drugs are antibiotics, antifungal, cardiac and diabetes management medicines.
Its manufacturing facilities are located in Assam and Himachal Pradesh.